Evaluation of Thiazolidine Derivatives with Potential Anti-ZIKV Activity

Results: Among them, six demonstrated remarkable selectivity against the ZIKV virus, exhibiting IC50 values of <5μM, and the other compounds did not demonstrate selectivity for the virus. Interestingly, several derivatives effectively suppressed the replication of ZIKV RNA copies, with derivatives significantly reducing ZIKV mRNA levels at 24 hours post-infection (hpi). Notably, two derivatives (ZKC-4 and -9) stood out by demonstrating a protective effect against ZIKV cell entry. Informed by computational analysis of binding affinity and intermolecular interactions within the NS5 domain's N-7 and O'2 positions, ZKC-4 and FT-39 displayed the highest predicted affinities. Intriguingly, ZKC-4 and ZKC-9 derivatives exhibited the most favorable predicted binding affinities for the ZIKV-E binding site.

Conclusion: The significance of TZDs as potent antiviral agents is underscored by these findings, suggesting that exploring TZD derivatives holds promise for advancing antiviral therapeutic strategies.

References

Crooks C, Weiler A, Rybarczyk S, Bliss M, Jaeger A, Murphy M . Previous exposure to dengue virus is associated with increased Zika virus burden at the maternal-fetal interface in rhesus macaques. PLoS Negl Trop Dis. 2021; 15(7):e0009641. PMC: 8357128. DOI: 10.1371/journal.pntd.0009641. View

Epelboin Y, Talaga S, Epelboin L, Dusfour I . Zika virus: An updated review of competent or naturally infected mosquitoes. PLoS Negl Trop Dis. 2017; 11(11):e0005933. PMC: 5690600. DOI: 10.1371/journal.pntd.0005933. View

Lima M, de Mendonca L, Rezende A, Carrera R, Anibal-Silva C, Demers M . The Transcriptional and Protein Profile From Human Infected Neuroprogenitor Cells Is Strongly Correlated to Zika Virus Microcephaly Cytokines Phenotype Evidencing a Persistent Inflammation in the CNS. Front Immunol. 2019; 10:1928. PMC: 6707094. DOI: 10.3389/fimmu.2019.01928. View

Ferraris P, Yssel H, Misse D . Zika virus infection: an update. Microbes Infect. 2019; 21(8-9):353-360. DOI: 10.1016/j.micinf.2019.04.005. View

Sironi M, Forni D, Clerici M, Cagliani R . Nonstructural Proteins Are Preferential Positive Selection Targets in Zika Virus and Related Flaviviruses. PLoS Negl Trop Dis. 2016; 10(9):e0004978. PMC: 5010288. DOI: 10.1371/journal.pntd.0004978. View

Lin H, Yip B, Huang L, Wu S . Zika virus structural biology and progress in vaccine development. Biotechnol Adv. 2017; 36(1):47-53. DOI: 10.1016/j.biotechadv.2017.09.004. View

Duan W, Song H, Wang H, Chai Y, Su C, Qi J . The crystal structure of Zika virus NS5 reveals conserved drug targets. EMBO J. 2017; 36(7):919-933. PMC: 5376968. DOI: 10.15252/embj.201696241. View

Agrelli A, Rodrigues de Moura R, Crovella S, Brandao L . ZIKA virus entry mechanisms in human cells. Infect Genet Evol. 2019; 69:22-29. DOI: 10.1016/j.meegid.2019.01.018. View

Coutard B, Barral K, Lichiere J, Selisko B, Martin B, Aouadi W . Zika Virus Methyltransferase: Structure and Functions for Drug Design Perspectives. J Virol. 2016; 91(5). PMC: 5309936. DOI: 10.1128/JVI.02202-16. View

10.

Godoy A, Lima G, Oliveira K, Torres N, Maluf F, Guido R . Crystal structure of Zika virus NS5 RNA-dependent RNA polymerase. Nat Commun. 2017; 8:14764. PMC: 5378953. DOI: 10.1038/ncomms14764. View

11.

Venkataraman S, Prasad B, Selvarajan R . RNA Dependent RNA Polymerases: Insights from Structure, Function and Evolution. Viruses. 2018; 10(2). PMC: 5850383. DOI: 10.3390/v10020076. View

12.

Mottin M, Borba J, Braga R, Torres P, Martini M, Proenca-Modena J . The A-Z of Zika drug discovery. Drug Discov Today. 2018; 23(11):1833-1847. PMC: 7108251. DOI: 10.1016/j.drudis.2018.06.014. View

13.

Saiz J . Therapeutic Advances Against ZIKV: A Quick Response, a Long Way to Go. Pharmaceuticals (Basel). 2019; 12(3). PMC: 6789873. DOI: 10.3390/ph12030127. View

14.

Baz M, Boivin G . Antiviral Agents in Development for Zika Virus Infections. Pharmaceuticals (Basel). 2019; 12(3). PMC: 6789597. DOI: 10.3390/ph12030101. View

15.

Musaddiq S, Shahzad M, Firdous F, Iqbal A, Tanveer M, Ashraf A . Thiazolidines: Potential anti-viral agents against avian influenza and infectious bronchitis viruses. Vet Res Forum. 2021; 11(4):415-421. PMC: 7904115. DOI: 10.30466/vrf.2018.91264.2211. View

16.

de Oliveira M, Viana D, Silva A, Pereira M, Duarte F, Pitta M . Synthesis of novel thiazolidinic-phthalimide derivatives evaluated as new multi-target antiepileptic agents. Bioorg Chem. 2021; 119:105548. DOI: 10.1016/j.bioorg.2021.105548. View

17.

Annamalai A, Pattnaik A, Sahoo B, Muthukrishnan E, Natarajan S, Steffen D . Zika Virus Encoding Nonglycosylated Envelope Protein Is Attenuated and Defective in Neuroinvasion. J Virol. 2017; 91(23). PMC: 5686755. DOI: 10.1128/JVI.01348-17. View

18.

Lanciotti R, Kosoy O, Laven J, Velez J, Lambert A, Johnson A . Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis. 2008; 14(8):1232-9. PMC: 2600394. DOI: 10.3201/eid1408.080287. View

19.

Modis Y, Ogata S, Clements D, Harrison S . A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci U S A. 2003; 100(12):6986-91. PMC: 165817. DOI: 10.1073/pnas.0832193100. View

20.

Durrant J, McCammon J . BINANA: a novel algorithm for ligand-binding characterization. J Mol Graph Model. 2011; 29(6):888-93. PMC: 3099006. DOI: 10.1016/j.jmgm.2011.01.004. View